Obesity significantly alters the human sperm proteome, with potential implications for fertility

T Pini1, J Parks2, J Russ2

  • 1Colorado Center for Reproductive Medicine, Lone Tree, CO, 80124, USA. tpini@flcolo.com.

Abstract

Insights

Obesity in men alters sperm proteins, increasing oxidative stress and inflammation, which may impair fertility. These molecular changes are not detected by standard semen analysis, highlighting a gap in assessing male reproductive health.

Area of Science:

  • Reproductive Biology
  • Proteomics
  • Male Infertility

Background:

  • Obesity is linked to reduced male fertility, but molecular mechanisms remain unclear.
  • Understanding the impact of obesity on the sperm proteome is crucial for male reproductive health.
  • Investigating molecular changes in sperm due to obesity can reveal novel insights into infertility.

Purpose of the Study:

  • To investigate how obesity modifies the human sperm proteome.
  • To identify specific proteins affected by obesity in spermatozoa.
  • To elucidate the molecular implications of obesity for male fertility.

Main Methods:

  • Sperm protein lysates from healthy weight and obese men were analyzed using liquid chromatography tandem mass spectrometry.
  • Label-free quantification was employed to compare protein abundance between groups.
  • Findings were validated using immunofluorescence and protein immunoassays.

Main Results:

  • A total of 2034 proteins were identified in human sperm.
  • Obese men showed significantly lower abundance of 24 proteins and higher abundance of 3 proteins compared to healthy weight controls.
  • Altered proteins were involved in oxidative stress, inflammation, DNA repair, translation, and sperm function.

Conclusions:

  • Obesity is associated with increased oxidative stress and inflammation in sperm, impacting reproductive function.
  • These molecular changes likely affect protein synthesis and folding during spermatogenesis, leading to subfertility.
  • Standard clinical semen assessments may not detect these crucial biochemical alterations in obese men, underscoring the need for advanced diagnostic approaches.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
167
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
128
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
486
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
120.8K